View Single Post
Old 02-01-2021, 10:17   #1465
Pete
Quiet Professional
 
Pete's Avatar
 
Join Date: Feb 2005
Location: Fayetteville
Posts: 13,080
Funny this study comes out now.

"Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection"

https://www.sciencedirect.com/scienc...02934320306732

".....Hydroxychloroquine (HCQ) is an antimalarial/anti-inflammatory drug that impairs endosomal transfer of virions within human cells. HCQ is also a zinc ionophore that conveys zinc intracellularly to block the SARS-CoV-2 RNA-dependent RNA polymerase, which is the core enzyme of the virus replication.21 The currently completed retrospective studies and randomized trials have generally shown these findings: 1) when started late in the hospital course and for short durations of time, antimalarials appear to be ineffective, 2) when started earlier in the hospital course, for progressively longer durations and in outpatients, antimalarials may reduce the progression of disease, prevent hospitalization, and are associated with reduced mortality.22, 23, 24, 25 ..."

But of course we knew that way back when - while Trump was still President.
Pete is offline   Reply With Quote